1 – 10 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Hypo, Hyper, or Combo : New paradigm for treatment of acute myeloid leukemia in older people
- Introducing patient-reported outcome in the acute leukemia quality registries in Sweden
- The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting
- Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years
- 2019
- Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting
- Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period
- 2018
- Acute myeloid leukemia in very old patients
- 2017
- The impact of socio-economic factors on treatment choice and mortality in chronic myeloid leukaemia
- Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register
- Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia : A population-based study from the Swedish AML registry